Forty Seven, Inc.

Home » Forty Seven, Inc.

IPO

Forty Seven, Inc.

We are a clinical-stage immuno-oncology company focused on developing novel checkpoint therapies to activate macrophages in the fight against cancer.

Symbol

FTSV

Price Range
$14.00 - $16.00

Final Shares
6,700,000

Anticipated Date
TBD

Underwriters
MORGAN STANLEY, CREDIT SUISSE, CANACCORD GENUITY, BTIG, OPPENHEIMER & CO.

To view the prospectus for Forty Seven, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253